JP2010536356A5 - - Google Patents

Download PDF

Info

Publication number
JP2010536356A5
JP2010536356A5 JP2010521365A JP2010521365A JP2010536356A5 JP 2010536356 A5 JP2010536356 A5 JP 2010536356A5 JP 2010521365 A JP2010521365 A JP 2010521365A JP 2010521365 A JP2010521365 A JP 2010521365A JP 2010536356 A5 JP2010536356 A5 JP 2010536356A5
Authority
JP
Japan
Prior art keywords
cyclic peptide
cys
amino acid
xxx
cyclo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010521365A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536356A (ja
JP5248610B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/006932 external-priority patent/WO2009027063A2/en
Publication of JP2010536356A publication Critical patent/JP2010536356A/ja
Publication of JP2010536356A5 publication Critical patent/JP2010536356A5/ja
Application granted granted Critical
Publication of JP5248610B2 publication Critical patent/JP5248610B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010521365A 2007-08-24 2008-08-22 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド Expired - Fee Related JP5248610B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07016637 2007-08-24
EP07016637.6 2007-08-24
PCT/EP2008/006932 WO2009027063A2 (en) 2007-08-24 2008-08-22 MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2013046776A Division JP2013176369A (ja) 2007-08-24 2013-03-08 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド
JP2013046777A Division JP2013138679A (ja) 2007-08-24 2013-03-08 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド

Publications (3)

Publication Number Publication Date
JP2010536356A JP2010536356A (ja) 2010-12-02
JP2010536356A5 true JP2010536356A5 (enExample) 2012-11-29
JP5248610B2 JP5248610B2 (ja) 2013-07-31

Family

ID=40130559

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010521365A Expired - Fee Related JP5248610B2 (ja) 2007-08-24 2008-08-22 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド
JP2013046776A Pending JP2013176369A (ja) 2007-08-24 2013-03-08 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド
JP2013046777A Pending JP2013138679A (ja) 2007-08-24 2013-03-08 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013046776A Pending JP2013176369A (ja) 2007-08-24 2013-03-08 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド
JP2013046777A Pending JP2013138679A (ja) 2007-08-24 2013-03-08 β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド

Country Status (13)

Country Link
US (1) US9062095B2 (enExample)
EP (3) EP2559698B1 (enExample)
JP (3) JP5248610B2 (enExample)
CN (2) CN103992406A (enExample)
AU (1) AU2008291296B2 (enExample)
CA (1) CA2697108C (enExample)
DK (1) DK2197900T3 (enExample)
ES (1) ES2391358T3 (enExample)
HR (1) HRP20120827T1 (enExample)
PL (1) PL2197900T3 (enExample)
PT (1) PT2197900E (enExample)
SI (1) SI2197900T1 (enExample)
WO (1) WO2009027063A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2559698B1 (en) * 2007-08-24 2014-11-12 Julius-Maximilians-Universität Würzburg Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies
WO2010086337A1 (en) * 2009-01-27 2010-08-05 Julius-Maximilians-Universität Würzburg Novel peptide-homologues for inhibiting beta1-adrenoceptor antibodies
DE102010018878B4 (de) 2009-04-30 2013-09-26 Julius-Maximilians-Universität Würzburg Neue Zell-Linie zur Fluoreszenz-basierten Detektion von funktionell aktiven Antikörpern und Autoantikörpern gegen den Beta1-adrenergen Rezeptor
EP2402016A1 (en) * 2010-06-29 2012-01-04 Charité - Universitätsmedizin Berlin Aptamers that inhibit interaction between antibody and 1st or 2nd extracellular loop of human beta-1-adrenergic receptor
US20140273015A1 (en) 2011-06-10 2014-09-18 Corim- Mun Gmbh BINDING COMPOUNDS TO HUMAN Beta 1-ADRENORECEPTOR (Beta 1-AR) AND THEIR USE IN MEASUREMENT OF AUTO-ANTI- Beta 1-AR ANTIBODIES
EP2814514B1 (en) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
ES2708565T3 (es) 2013-03-15 2019-04-10 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
JPWO2015022953A1 (ja) * 2013-08-14 2017-03-02 国立大学法人 長崎大学 血液脳関門障害改善剤
CA3060514A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
CN108218963B (zh) * 2018-01-19 2020-10-13 首都医科大学 一种环肽及其制备方法和用途
EP3938403A1 (en) * 2019-03-14 2022-01-19 F. Hoffmann-La Roche AG Treatment of cancer with her2xcd3 bispecific antibodies in combination with anti-her2 mab
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
EP3715374A1 (en) 2019-03-23 2020-09-30 Ablevia biotech GmbH Compound for the sequestration of undesirable antibodies in a patient
EP4217402A1 (en) * 2020-09-23 2023-08-02 Ablevia biotech GmbH Compound for the prevention or treatment of autoantibody-mediated conditions
CN112266330B (zh) * 2020-10-15 2023-02-24 长沙博源医疗科技有限公司 一种甲氧基肾上腺素衍生物、免疫原、抗甲氧基肾上腺素特异性抗体及其制备方法与应用
WO2023028590A1 (en) * 2021-08-27 2023-03-02 Yale University Molecular degraders of extracellular proteins
JP2023117892A (ja) * 2022-02-14 2023-08-24 公益財団法人 鷹揚郷 ヘプシジン結合ペプチド
CN120647762B (zh) * 2025-06-16 2026-01-23 首都医科大学附属北京友谊医院 一种抗β1-AR-ECII抗体及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5792608A (en) 1991-12-12 1998-08-11 Gilead Sciences, Inc. Nuclease stable and binding competent oligomers and methods for their use
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
WO2001034208A1 (en) * 1999-11-05 2001-05-17 The Regents Of The University Of California Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
KR20020047177A (ko) * 1999-09-21 2002-06-21 아피나 이문테히닉 게엠베하 확장성 심근질환을 유발하는 자동항체를 제거하기 위한펩티드
US20040001827A1 (en) * 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
JP4541490B2 (ja) * 2000-04-07 2010-09-08 株式会社カネカ 拡張型心筋症用吸着体
WO2001083693A2 (en) * 2000-04-28 2001-11-08 Glaxo Group Limited Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
CN1988914A (zh) * 2001-08-23 2007-06-27 西兰制药公司 胞间通讯易化化合物的新医学用途
US7041790B2 (en) * 2002-03-26 2006-05-09 Dyax Corp. Fibrinogen binding moieties
US20080206264A1 (en) * 2003-02-04 2008-08-28 New York University Constrained Hiv V3 Loop Peptides as Novel Immunogens and Receptor Antagonists
EP1536020A1 (en) 2003-11-26 2005-06-01 Bayerische Julius-Maximilians-Universität Würzburg Means and methods for optical determination of cAMP in vitro and in vivo
WO2006103101A2 (en) * 2005-03-31 2006-10-05 Julius-Maximilians-Universität Würzburg MEANS FOR THE INHIBITION OF ANTI-β1-ADRENERGIC RECEPTOR ANTIBODIES
EP2559698B1 (en) * 2007-08-24 2014-11-12 Julius-Maximilians-Universität Würzburg Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies

Similar Documents

Publication Publication Date Title
JP2010536356A5 (enExample)
CN102711802B (zh) 肽glp‑2激动剂
HRP20120827T1 (hr) Mutantni, dvostruko ciklizirani receptorski peptidi koji inhibiraju protutijela na adrenoceptor beta 1
JP4282485B2 (ja) 伸長グルカゴン様ペプチド−1アナログ
JP6325585B2 (ja) インターロイキン−22のウイルス性肝炎の治療における応用
JP2023524054A5 (enExample)
CN102917726B (zh) 干扰素类似物
CN116096735A (zh) 乙型冠状病毒的预防和治疗
US11306296B2 (en) MG53 mutants, methods of making the same, and uses thereof
TWI341844B (en) Hiv fusion inhibitor peptides with improved biological properties
JP2020528743A5 (enExample)
HUT70459A (en) Analogs of pth
AU2009312892A1 (en) Neuropeptide-2-receptor (Y-2r) agonists and uses thereof
US8906355B2 (en) Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
EA036479B1 (ru) Пептид, активирующий рецептор гпп-1 и рецептор глюкагона, фармацевтическая композиция на его основе и их применение для профилактики или лечения ожирения
JP2010535504A5 (enExample)
KR20180038557A (ko) 타겟 폴리펩티드를 제시하기 위한 폴리펩티드 캐리어 및 이의 용도
JP2022500069A (ja) サイトカイン放出を刺激しうる新規ペプチド及びその誘導体
CN102153654B (zh) 以免疫活性肽为载体的分支多肽及其衍生物与应用
JP2004510426A (ja) 多発性硬化症の治療におけるケモカイン変異体
CN118561986A (zh) 一种犬α干扰素突变体及其应用
JP7499533B2 (ja) 新規アドレノメデュリン類縁体、その製造方法及びその医薬用途
CN1869072A (zh) 与胶原特异结合的神经生长因子及其编码基因与应用
CN106699860B (zh) 三种改造环状多肽及其应用和抗菌制剂
JP2004518410A5 (enExample)